ALPS
Alps Group Inc
NASDAQ · Healthcare · Biotechnology · MY
$0.37
−2.63%Institutional positioning
13F filings over the trailing two quarters
New 2Increased 0Reduced 3Sold out 6
| Filer | Action | Shares | Filed |
|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | Reduced | 387,495 | May 15, 2026 |
| MMCAP INTERNATIONAL INC. SPC | Unchanged | 54,000 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 42,160 | Sep 2, 2026 |
| JONES FINANCIAL COMPANIES LLLP | New Position | 24,950 | May 15, 2026 |
| SABA CAPITAL MANAGEMENT, L.P. | Reduced | 14,054 | May 15, 2026 |
| ARISTEIA CAPITAL LLC | Unchanged | 11,851 | May 15, 2026 |
| SKYVIEW INVESTMENT ADVISORS, LLC | Unchanged | 10,000 | May 15, 2026 |
| UBS GROUP AG | Reduced | 1,628 | May 5, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| MMCAP International Inc. SPC | Sold Out | 0 | May 15, 2026 |
| Saba Capital Management, L.P. | Sold Out | 0 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Sold Out | 0 | May 15, 2026 |
| ARISTEIA CAPITAL, L.L.C. | Sold Out | 0 | May 15, 2026 |
| JONES FINANCIAL COMPANIES LLLP | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings